Clastogenic activity in the plasma of scleroderma patients: A biomarker of oxidative stress

Dermatology

Volumn 194, Issue 2, 1997, Pages 140-146

  Emerit, I ^a   Filipe, P ^a   Meunier, P ^a   Auclair, C ^c   Freitas, J ^b   Deroussent, A ^c   Gouyette, A ^c   Fernandes, A ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITY OF LISBON   (Portugal)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Adenosine deaminase; Antioxidants; Chromosomal breakage; Clastogenic factors; Inosine triphosphate; Oxidative stress; Scleroderma; Superoxide dismutase

Indexed keywords

ADENOSINE DEAMINASE; BIOLOGICAL MARKER; CLASTOGEN; INOSINE TRIPHOSPHATE; MALONALDEHYDE; SUPEROXIDE;

ADULT; AGED; ARTICLE; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DEAMINATION; DISEASE ACTIVITY; ESOPHAGUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PLASMA; PLASMA FACTOR; PRIORITY JOURNAL; SCLERODERMA; SKIN;

EID: 0030971874     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246083     Document Type: Article

References (41)

1. Murrcl DF: A radical proposal for ihe pathogenesis of scleroderma. J Am Acad Dermatol 1993;28:78-85.
2. Enterit I: Chromosomal breakage in systemic-sclerosis and related disorders. Dermalologica 1976;153:145-156.
3. Emerit I. Levy A. Housset E: Breakage factor in systemic sclerosis and protector effect of /.-cysteine. Hum Genet 1974:25:221-226.
4. Emerit I: Chromosome breakage factors: origin and possible significance, Progr Mutai Res 1982:4:61-74.
5. Goh KH. Summer H: Breaks in normal chromosomes: Are they induced by a transferable substance in the plasma of persons exposed to total body irradiation? Radiat Res 1968:35: 171-181.
6. Hollowed JG. Littlefield LG: Chromosome damage induced by plasma from irradiated patients. Proc Soc Exp Biol Med 1968:29: 240-244.
7. Emerit I: Chromosomal instability in collagen disease. Z Rheumatol 1980:39:84-90.
8. Emerit I. Michelson M: Chromosome breaking factor in the serum of patients with collagen disease. Protective effect of superoxide disntu-tase: in Bannister WH. Bannister JV (eds): Biological and Clinical Aspects of Superoxide and Superoxide Dismutase. Amsterdam. Else-vier/North Holland, 1980. pp 384-394.
9. Emerit I: Rationale for antioxidant therapy of rheumatoid diseases; in Davies KJA (cd): Oxidative Damage and Repair. New York. Pergamon Press. 1991. pp 862-869.
10. Khan SH, Emerit I: Lipid peroxidation products and dastogenic material in culture media of human leukocytes exposed to the tumor promoter phorbol-myristate-acetate. Free Radic Biol Med 1985;1:443-449.
11. Emerit I. Khan SII. Cerutli PA: Treatment of lymphocyte cultures with a hypoxanthine-xan-thine oxidase system induces the formation of transferable dastogenic material. Free Radic Biol Med 1985:1:51-57.
12. Emerit I. Aulor A. Auclair C, Levy A. Ens-worth S. Lahoud-Maghani M, Stein H. Camus P: Role of oxygen free radicals in progressive systemic sclerosis (scleroderma); in Hayashi O. Niki E. Kondo M. Yoshikawa T (eds): Medical, Biochemical and Chemical Aspects of Free Radicals. Amsterdam. Elsevier. 1989. pp 1211-1218.
13. Emerit I: Reactive oxygen species, chromosome mutation, and cancer: Possible role of dastogenic factors in carcinogenesis. Free Radic Biol Med 1994:16:99-109.
14. Emerit I, Khan SH, Eslerbauer H: Hydroxy-nonenal. a component of dastogenic factors? Free Radic Biol Med 1991:10:371-377.
15. Kozumbo WJ. Muehlemaltcr D. Jdrg A. Emerit I. Cerulii PA: Phorbol ester-induced formation of clastogenic factor from human monocytes. Carcinogenesis 1987:8:521-526.
16. Emerit I. Levy A. Pagano G. Pinto L. Calone R. Zatterale A: Transferable clastogenic activity in plasma from patients with Eanconi anemia. Hum Genet 1995:96:14-20.
17. Auclair C. Gouyetle A. Levy A. Emerit I: Clastogenic ¡nosine nucleotides as components of the chromosome breakage factor in scleroderma patients. Arch Biochem Biophys 1990: 278:238-241.
18. Meunier P. Filipc P. Emerit I. Freitas J. Guerra Rogrigo F. Manso C: Adenosine deaminase in progressive systemic sclerosis. Acta Derm Ve-ncreol (Stock'll) 1995:75:297-299.
19. Sasaki T. Nakajimi H: Scrum adenosine deaminase activity in systemic sclerosis and related disorders. J Am Acad Dermatol 1992:27: 411-414.
20. Masi AT. Rodnan GP. Medsger TA Jr. Altman RD. D'Angelo WA. Fries JE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980:23: 581-590.
21. Emerit I.: Clastogenic factors: Detection and assay: in: Packer L. Glazer AN (eds): Methods in Enzymology. New York. Academic Press. 1990. pp 555-564.
22. Giusti G. Galanti B: Colorimetric methods; in Bergmeyer HU (ed): Methods of Enzymatic Analysis, cd 3. Weinheim. Verlag Chemie, 1984. pp 315-323.
23. Yagi K: Assay for serum lipid peroxide level and its clinical significance: in Yagi K (ed): Lipid peroxidation. Academic Press New York. 1982. pp 223-242.
24. Yokoyama Y. Beckman JS. Beckman TK. Wheat JK. Cash TG. Freeman B. Parks DA: Circulating xanthine oxidase: potential mediator of ischemic injury. Am J Physiol 1990:258: G564-G570.
25. Miesel R. Zuber M: Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases. Inflammation 1993:17:551-561.
26. Emerit I. Fabiani JN. Levy A. Ponzio Q. Conti M. Brasme B. Bienvenu P. Hatmi M: Plasma from patients exposed to ischemia reperfusion contains clastogenic factors and stimulates the chemiluminescence response of normal leukocytes. Free Radie Biol Med 1995:19:405-415.
27. Emerit I. Emerit J. Levy A. Keck M: Chromosomal breakage in Crohn’s disease: Anticlasto-genic effect of /7-penicillamine and /.-cysteine. Hum Genet 1979:50:51-57.
28. Ocana I. Segura RM. Fernandez de Sevilla T. Capdevila JA: Adenosine deaminase in pleural fluids, test for diagnosis of tuberculous pleural effusion. Chest 1983:84:51-53.
29. Jaqueti J. Martinez-Hernandez D. Hernandez-Garcia R. Navarro-Gallar F: Adenosine deaminase increased in serum in toxoplasmosis (letter). Clin Chem 1991:37:20-21.
30. Galanti B. Nardiellc S. Russo M. Firorentino F: Increased lymphocyte adenosine deaminase in typhoid fever. Stand J Infect Dis 1981:13: 47-50.
31. Ungercr JPJ. Oosthuizen HM. Bissbort SH. Vermaak WJH: Serum adenosine deaminase: Isoenzymes and diagnostic application. Clin Chem 1992:38:1322-1326.
32. Niedzwicki JG. Mayer KH. Abushanab E. Abernethy DR: Plasma adenosine deaminase 2 is a marker for human immunodeficiency virus-1 seroconversion. Am J Hematol 1991: 37:152-155.
33. Smyth JF. Poplack DH. Holman BJ. Leventhal BG. Yarbro G: Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. J Clin Invest 1979:62: 710-712.
34. Van Jer Weyden MB. Kelley WN: Human adenosine deaminase. Distribution and properties. J Biol Chem 1976;251:5448-5456.
35. Karran P. Lindahl T: Enzymatic excision of free hypoxanthine from polydcoxynucleo-t ides and DNA containing deoxyinosine monophosphate residues. J Biol Chem 1978:253: 5877-5879.
36. Karran P. Lindahl T: Hypoxanthine in deoxyribonucleic acid: Generation by heat-induced hydrolysis of adenine residues and release in free form by a deoxyribonucleic acid glycol-ase from calf thymus. Biochemistry 1980:19: 6005-6011.
37. Shkakis P. Tesar J. Theocharis S: Increased frequency of in vivo hprt gene-mutated T cells in the peripheral blood of patients with systemic sclerosis. Am Rheum Dis 1994:53:122-127.
38. Osheroff N, Shelton F.R. Brutlag DL: DNA lopoisomerase II from Drosophila melano-gasier. J Biol Chem 1983:258:9536-9543.
39. Wang C: DNA topoisomcrases. Annu Rev Biochem 1985:54:665-697.
40. Kuhns DB. Wright DG. Nath I. Kaplan S. Basford RE: ATP induces transient elevation of intracellular free calcium concentration in human neutrophils and primes these cells for enhanced O. generation. Lab Invest 1988:58: 448-453.
41. Emerit I. Oganesian N. Sarkisian T. Arutyun-yan R. Pogosian A. Asrian K. Levy A. Cem-javski L: Clastogenic factors in the plasma of Chernobyl accident recovery workers: Anti-clastogenic effect of Ginkgo hiloha extract. Radiât Res 1995:144:198-205